Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma

Journal:

Nature Communications

Published:

2025-11-11

DOI:

10.1038/s41467-025-64860-7

Affiliations:

9

Authors:

21

Go to article

Institutions	Authors	Share
The Hong Kong Polytechnic University (PolyU), China	10.000000 10.000000	0.48
The Chinese University of Hong Kong (CUHK), China	5.000000	0.24
Li Ka Shing Faculty of Medicine, HKU, China	3.500000	0.17
Sun Yat-sen University Cancer Center (SYSUCC), SYSU, China	1.000000	0.05
Second Military Medical University (SMMU), China	1.000000	0.05
State Key Laboratory of Liver Research, HKU, China	0.500000	0.02

Interested in Oncology and Carcinogenesis?